BioSpace News Archive

AbbVie, a research-based global biopharmaceutical company, today announced a donation of $5 million to Family Reach to support the organization’s efforts to alleviate the financial burden of cancer on pediatric patients and families across the United States.

The Pharmaceutical Research and Manufacturers Association (PhRMA), the drug industry’s trade group and lobbying arm, donated $500,000 to the ‘No on 10’ campaign, joining with greedy billionaire corporate landlords to oppose Prop. 10, a November ballot measure that will empower communities to limit rent increases and address California’s housing affordability crisis.

Blue Cross is in top 10 percent of plans nationally

According to the market research report released by Technavio, the global optical coherence tomography market is expected to accelerate at a CAGR of more than 8% during the forecast period.

Viking Therapeutics, Inc. today announced the pricing of its public offering of 9,500,000 shares of its common stock at a price to the public of $18.50 per share.

Innovent Biologics, Inc. (Innovent), a world-class China-based biopharmaceutical company that develops and commercializes high quality drugs, today presented clinical trial data from a phase Ib clinical trial (NCT02937116) that treated patients with neuroendocrine tumors

SCOUT, a leading healthcare marketing agency focused on orphan drugs and specialty pharmaceuticals, has formed a joint venture with Rare Expertise, a company with proprietary data-driven tools for identifying and activating people with rare disorders.

pen Medicine Foundation (OMF), the premier nonprofit organization investing in research to cure myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), sponsors the Second Annual Community Symposium on the Molecular Basis of ME/CFS on September 29, 2018, at Stanford University.

In-Shape Health Clubs, California’s top destination for fitness and recreation, today announced its goal to raise $150,000 for cancer research in the month of October for its 4th annual Fight Cancer campaign.

Arcus Biosciences, Inc. (NYSE:RCUS), today announced Terry Rosen, Ph.D., Chief Executive Officer, and Jennifer Jarrett, Chief Operating Officer and Chief Financial Officer, will participate in a fireside chat at the Leerink Partners Roundtable Series: Rare Disease & Oncology on Wednesday, October 3, 2018, at 10:30 am ET at the Lotte New York Palace, in New York.